Gene · 1630
DCC: DCC netrin 1 receptor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DCC: DCC netrin 1 receptor. Genes, record 1630. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1630
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P43146 | Netrin receptor DCC | 1,447 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents26
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 13380 | P43146 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1221 | P43146 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1221 | P43146 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 13380 | P43146 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27105 | P43146 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 27105 | P43146 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5877 | P43146 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 27105 | P43146 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 22503 | P43146 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3231 | P43146 | Espacenet |
1 to 10 of 26
See all 26 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,488
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DCC papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 22 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 8 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 8 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 6 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 6 | 2025 |
| R01CA109182 | Functional Determinants of Metastatic Dormancy | 6 | 2025 |
| ZIADK031116 | Development of P2Y Receptor Ligands | 6 | 2025 |
1 to 10 of 2,488Source NIH's project files
See all 2,488 nih grantsPapers3,713
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of comprehensive genetic factors, pathways, and shared genetic architecture of putamen volume in adolescent cohort. | Transl Psychiatry | 2026 | 42816494 | PubTator, text mining | PubMed |
| Isolation, characterization, and optimization of extracellular laccase-producing bacteria from dye-contaminated textile wastewater for dye decolonization. | PLoS One | 2026 | 42809563 | PubTator, text mining | PubMed |
| The Fragile Site Landscape of Induced Pluripotent Stem Cells: Hierarchy, Variability, Tissue Specificity, and Links to Culture-Acquired Rearrangements. | Cells | 2026 | 42738851 | PubTator, text mining | PubMed |
| Development of Netrin-1-targeted peptide probes derived from the Netrin-1/DCC complex for noninvasive imaging of tumors. | Bioorg Chem | 2026 | 42702132 | PubTator, text mining | PubMed |
| Acute respiratory viral inflammation and metastatic dormancy: direct evidence, mechanistic convergence, and research priorities. | Cancer Treat Res Commun | 2026 | 42664754 | PubTator, text mining | PubMed |
| Fluorescently Labelled Polypropylene as a Model Microplastic for Cellular Imaging. | Polym Chem | 2026 | 42626445 | PubTator, text mining | PubMed |
| Genetic Variation in ADHD-Related Risk Genes in an Indigenous Population of the Amazon. | Am J Med Genet B Neuropsychiatr Genet | 2026 | 42581023 | PubTator, text mining | PubMed |
| GAS2 Co-Expression Networks in Breast Cancer: Identification of Potential Biomarkers and Therapeutic Targets. | Adv Pharm Bull | 2026 | 42524055 | PubTator, text mining | PubMed |
| The genetic architecture of fibromyalgia across 2.5 million individuals. | Nat Med | 2026 | 42521817 | PubTator, text mining | PubMed |
| Distinct conformational dynamics of the type-2 Angiotensin II receptor bound to Angiotensin II and Angiotensin (1-7). | Sci Rep | 2026 | 42477346 | PubTator, text mining | PubMed |
1 to 10 of 3,713
See all 3,713 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1630
GET https://conductscience.org/api/genes/v1/1630/patents?page=2